Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board has determined that the veteran's postoperative residuals of a shell fragment wound of the left knee warrant an increased evaluation to 30 percent, effective from November 1985.

The deciding factor: The evidence shows significant limitation of motion, pain, muscle atrophy and weakness with mild paralysis of the anterior tibial nerve, as well as occasional effusion and subjective reports of locking. These findings are consistent with a rating of 30 percent under Diagnostic Codes 8523-5260.

Claimed conditions
Postoperative residuals of a shell fragment wound of the left knee
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
30%
Decision date
July 31, 2001
Citation
0119758

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0119758.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.